New Key Statistics Module, Z-Score and F-Score
NAS:FIXX Key Ratios
| Market Cap $ M | 3.02 |
| Enterprise Value $ M | -78.32 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.04 |
| Price/Sales | 2.60 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -35.10 |
| Beneish M-Score | -4.55 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 5.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.85 |
| EV-to-EBITDA | 0.86 |
| PEG | -- |
| Shares Outstanding M | 3.23 |
| Net Margin (%) | -9,771.71 |
| Operating Margin % | -7,967.30 |
| Pre-tax Margin (%) | -7,532.87 |
| Quick Ratio | 7.25 |
| Current Ratio | 7.25 |
| ROA % (ttm) | -68.85 |
| ROE % (ttm) | -92.52 |
| ROIC % (ttm) | -232.80 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.18 |
FIXX Number of Guru Trades
FIXX Volume of Guru Trades
Gurus Latest Trades with NAS:FIXX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FIXX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Homology Medicines Inc Insider Transactions
No Available Data
News about NAS:FIXX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers